A review of nanotechnology-based approaches for breast cancer and triple-negative breast cancer

V Jain, H Kumar, HV Anod, P Chand, NV Gupta… - Journal of Controlled …, 2020 - Elsevier
Breast cancer (BC) is one of the most prevalent cancers in women. Triple-negative breast
cancer (TNBC) in which the three major receptors ie estrogen receptor (ER), progesterone …

Getting into the brain: liposome-based strategies for effective drug delivery across the blood–brain barrier

DB Vieira, LF Gamarra - International journal of nanomedicine, 2016 - Taylor & Francis
This review summarizes articles that have been reported in literature on liposome-based
strategies for effective drug delivery across the blood–brain barrier. Due to their unique …

[HTML][HTML] Advances in nanomaterials for the diagnosis and treatment of head and neck cancers: A review

C Yu, L Li, S Wang, Y Xu, L Wang, Y Huang, A Hieawy… - Bioactive Materials, 2023 - Elsevier
Nanomaterials (NMs) have increasingly been used for the diagnosis and treatment of head
and neck cancers (HNCs) over the past decade. HNCs can easily infiltrate surrounding …

Advances in biomedical applications of self-healing hydrogels

H Rammal, A GhavamiNejad, A Erdem… - Materials Chemistry …, 2021 - pubs.rsc.org
Hydrogels are important biomaterials that have several applications in drug and cell
delivery, tissue engineering, three-dimensional (3D) printing and more recently, in sensing …

Targeted therapeutic nanoparticles: an immense promise to fight against cancer

ST Jahan, SMA Sadat, M Walliser… - Journal of drug …, 2017 - Wiley Online Library
In nanomedicine, targeted therapeutic nanoparticle (NP) is a virtual outcome of
nanotechnology taking the advantage of cancer propagation pattern. Tying up all elements …

Nanoparticle-based therapeutic strategies targeting major clinical challenges in pancreatic cancer treatment

M Tarannum, JL Vivero-Escoto - Advanced Drug Delivery Reviews, 2022 - Elsevier
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers due to its
aggressiveness and the challenges for early diagnosis and treatment. Recently …

Lipidic cubic-phase leflunomide nanoparticles (cubosomes) as a potential tool for breast cancer management

M Zewail, PM E. Gaafar, MM Ali, H Abbas - Drug Delivery, 2022 - Taylor & Francis
Despite the fact of availability of several treatments for breast cancer, most of them fail to
attain the desired therapeutic response due to their poor bioavailability, high doses, non …

[HTML][HTML] Anthelmintics for drug repurposing: Opportunities and challenges

SE Alavi, HE Shahmabadi - Saudi Pharmaceutical Journal, 2021 - Elsevier
Drug repositioning is defined as a process to identify a new application for drugs. This
approach is critical as it takes advantage of well-known pharmacokinetics …

Traversing the diverse avenues of exopolysaccharides-based nanocarriers in the management of cancer

P Paul, R Nair, S Mahajan, U Gupta, M Aalhate… - Carbohydrate …, 2023 - Elsevier
Exopolysaccharides are unique polymers generated by living organisms such as algae,
fungi and bacteria to protect them from environmental factors. After a fermentative process …

Engineered nanomaterials as an effective tool for HER2+ breast cancer therapy

P Pandey, DK Arya, MK Ramar, K Chidambaram… - Drug Discovery …, 2022 - Elsevier
Highlights•Breast cancer (BC) is the most aggressive malignant cancer in women
worldwide.•Multidrug resistance (MDR), poor targeting, and high toxicity constrain …